AMGN · Amgen GP
last $409.02+0.70%volume $8.86Mmarket cap n/afeed alpacaas of 2026-09-25 15:32
one year · daily closes52-week high $443.9452-week low $271.281m -8.2%3m +15.1%1y +45.5%
FA · financials · Amgen Inc. from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| revenue | $10.05B | $8.62B | $9.87B | $9.56B | $9.18B | $8.15B | $9.09B | $8.50B |
| net income | $2.38B | $1.82B | $1.33B | $3.22B | $1.43B | $1.73B | $627.00M | $2.83B |
| EPS (diluted) | 4.37 | 3.34 | 2.46 | 5.93 | 2.65 | 3.20 | 1.16 | 5.22 |
| operating cash flow | $4.00B | $2.19B | $1.60B | $4.68B | $2.28B | $1.39B | $4.77B | $3.57B |
total assets $95.64B (2026-06-30)cash $13.99B (2026-06-30)long term debt $51.86B (2026-06-30)equity $11.69B (2026-06-30)shares outstanding 540,632,005 (2026-07-30)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · AMGNmore →
no matching headlines in the last hours